Search results for "Protozoa"

showing 10 items of 222 documents

Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily.

2007

The purpose of this study was to evaluate whether the risk of transfusion-transmitted visceral leishmaniasis was present in an area of western Sicily where the incidence of the disease is higher than the regional average. From May to December 2005, 1449 blood donors from Agrigento district (Sicily, Italy) were screened for the presence of anti-Leishmania antibodies by an indirect immunofluorescent antibody test (IFAT). Blood samples from IFAT-positive donors were examined by PCR to detect Leishmania DNA. Anti-Leishmania antibodies were found in 11 (0.75%) cases, among which Leishmania DNA was detected from four (36.4%). Particular techniques to inactivate different pathogens would be consid…

AdultMaleBlood transfusionSettore MED/17 - Malattie Infettivemedicine.medical_treatmentAntibodies ProtozoanBlood DonorsParasitemiaSettore MED/42 - Igiene Generale E Applicatalaw.inventionlawparasitic diseasesmedicineAnimalsHumansLeishmania infantumLeishmania blood donors asympthomatic infectionPolymerase chain reactionbiologyPublic Health Environmental and Occupational HealthGeneral MedicineLeishmania chagasiDNA ProtozoanMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaInfectious DiseasesVisceral leishmaniasisItalyImmunologyCarrier Statebiology.proteinLeishmaniasis VisceralParasitologyFemaleAntibodyLeishmania infantumTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Balantidiasis in Aymara children from the northern Bolivian Altiplano.

1998

Balantidium coli infection was coprologically studied in 2,124 Aymara children 5-19 years of age from the schools of 22 communities of the northern Bolivian Altiplano over a five-year period. Infection with B. coli was found in 11 of the communities surveyed, with prevalences of 1.0-5.3% (overall prevalence=1.2%). The prevalences observed are some of the highest reported and did not differ significantly among the various age groups or between boys and girls. These prevalences, the apparent absence of symptoms or signs of illness due to this parasite in the schoolchildren surveyed at the time of stool sampling, and the consistency of stool samples of the infected students suggest that they a…

AdultMaleBoliviaAdolescentSwineAge groupsVirologymedicinePrevalenceAnimalsHumansBalantidiasisProtozoal diseaseChildBalantidium colibiologyBalantidiasisbiology.organism_classificationmedicine.diseaseInfectious DiseasesEl NiñoChild PreschoolParasitologyFemaleAsymptomatic carrierDemographyThe American journal of tropical medicine and hygiene
researchProduct

A study on occupational exposure of Sicilian farmers to Giardia and Cryptosporidium

2013

Introduction. A cross-sectional study was undertaken to deter- mine the prevalence of Giardia and Cryptosporidium in calves of Palermo area (Sicily) and to evaluate the occupational risk associated with occurrence of zoonotic genotypes. Methods. A total of 217 faecal samples, from 149 calves (between 2 and 240 days of age) and 68 farmers, were collected in 19 cattle- farms of Palermo area. A questionnaire regarding demographic characteristics and personal hygienic measures was submitted to all farmers. All faecal samples were analyzed by Immunoflu- orescence assay and Polimerase Chain Reaction (PCR); geno- types were determined by DNA sequencing of Triose Phosphate Isomerase gene for Giardi…

AdultMaleGiardia/CryptosporidiumAdolescentCryptosporidiumCalvesPolymerase Chain ReactionFecesYoung AdultOccupational Exposureparasitic diseasesAnimalsHumansGiardiaAgricultureSequence Analysis DNAMiddle AgedCross-Sectional StudiesGiardia Cryptosporidium Calves Occupational riskItalyRNA RibosomalOriginal ArticleCattleFemaleOccupational riskRNA ProtozoanTriose-Phosphate IsomeraseJournal of Preventive Medicine and Hygiene
researchProduct

Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1

2001

ABSTRACT A group of 76 consecutive human immunodeficiency virus (HIV)-positive patients with fever of unknown origin ( n = 52) or fever associated with pulmonary diseases was evaluated in order to assess the usefulness of PCR with peripheral blood in the diagnosis and follow-up of visceral leishmaniasis. We identified 10 cases of visceral leishmaniasis among the 52 patients with fever of unknown origin. At the time of diagnosis, all were parasitemic by PCR with peripheral blood. During follow-up, a progressive decline in parasitemia was observed under therapy, and all patients became PCR negative after a median of 5 weeks (range, 6 to 21 weeks). However, in eight of nine patients monitored …

AdultMaleMicrobiology (medical)Settore MED/17 - Malattie InfettiveLeishmania donovaniHIV InfectionsParasitemiaPolymerase Chain ReactionImmunopathologymedicineAnimalsHumansLeishmania infantumFever of unknown originbiologyLeishmaniasisDNA ProtozoanMiddle AgedPrognosisvisceral leishmaniasis; HIV; PCR diagnosisSettore MED/07 - Microbiologia e Microbiologia Clinicabiology.organism_classificationmedicine.diseaseVisceral leishmaniasisImmunologyHIV-1Leishmaniasis VisceralFemaleParasitologyViral diseaseLeishmania infantumPolymorphism Restriction Fragment LengthLeishmania donovaniJournal of Clinical Microbiology
researchProduct

Cryptic Leishmania infantum infection in Italian HIV infected patients.

2008

Abstract Background Visceral leishmaniasis (VL) is a protozoan diseases caused in Europe by Leishmania (L.) infantum. Asymptomatic Leishmania infection is more frequent than clinically apparent disease. Among HIV infected patients the risk of clinical VL is increased due to immunosuppression, which can reactivate a latent infection. The aims of our study were to assess the prevalence of asymptomatic L. infantum infection in HIV infected patients and to study a possible correlation between Leishmania parasitemia and HIV infection markers. Methods One hundred and forty-five HIV infected patients were screened for the presence of anti-Leishmania antibodies and L. infantum DNA in peripheral blo…

AdultMaleSettore MED/17 - Malattie InfettiveAntibodies ProtozoanHIV InfectionsParasitemiaBiologyParasitemiaAsymptomaticlcsh:Infectious and parasitic diseasesYoung Adultparasitic diseasesmedicinePrevalenceHumanslcsh:RC109-216Leishmania infantumAgedHIVLeishmaniasisDNA ProtozoanMiddle Agedmedicine.diseasebiology.organism_classificationVirologyCryptic infectionCryptic infectionVisceral leishmaniasisInfectious DiseasesPCRItalyImmunoglobulin GImmunologyCarrier StateLeishmaniasis VisceralRegression AnalysisFemalemedicine.symptomLeishmania infantumViral loadAsymptomatic carrierResearch Article
researchProduct

EPIDEMIOLOGICAL SURVEILLANCE OF VISCERAL LEISHMANIASIS IN SICILY, ITALY

1997

Abstract Visceral leishmaniasis (VL) is endemic in Sicily. Although it is a notifiable disease, there is evidence that the actual number of cases is higher than that reported. In 1987, a regional reference center for active surveillance of VL was established and it recorded a total of 284 cases through 1995, a mean of 31.5 cases/year and about four-fold more than previously reported. Of the 284 cases, 150 (53%) were children (≤ 14 years of age), and of the 134 adults, 39 (29%) were coinfected with human immunodeficiency virus (HIV). The commonest viscerotropic zymodeme of Leishmania infantum, MON 1, was identified in 40 (93%) of 43 HIV-negative and eight (57%) of 14 HIV-positive patients. A…

AdultMalemedicine.medical_specialtyAdolescentAllopurinolMeglumine antimoniateNotifiable diseaseAntiprotozoal AgentsHIV InfectionsCohort StudiesAge DistributionMeglumineRecurrenceAmphotericin BVirologyInternal medicineAmphotericin BEpidemiologyOrganometallic CompoundsmedicineAnimalsHumansLeishmania infantumSex DistributionChildSicilyleishmaniasisAgedMeglumine Antimoniatebiologybusiness.industryInfantLeishmaniasisMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryInfectious DiseasesVisceral leishmaniasisChild PreschoolLeishmaniasis VisceralAntimonialDrug Therapy CombinationFemaleParasitologyLeishmania infantumbusinessmedicine.drug
researchProduct

Vascular patterns in cutaneous leishmaniasis: A videodermatoscopic study

2015

AdultMalemedicine.medical_specialtyAdolescentBlood VesselVideo RecordingLeishmaniasis CutaneousDermoscopyDermatologySkin Diseases VascularYoung AdultCutaneous leishmaniasislcsh:DermatologyHumansMedicineLeishmania infantumChildAgedVideo recordingbiologybusiness.industryLeishmaniasis CutaneouLeishmaniasisDNA ProtozoanMiddle Agedlcsh:RL1-803biology.organism_classificationmedicine.diseaseDermatologyInfectious DiseasesChild PreschoolBlood VesselsFemaleVascular pathologyLeishmania infantumbusinessHuman2708Indian Journal of Dermatology, Venereology, and Leprology
researchProduct

Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional s…

2011

Cutaneous leishmaniasis (CL) is endemic in Central Africa, including Cameroon. However, data on its prevalence and co-infection with HIV are scarce. Here we present the results of a large cross-sectional study reporting the prevalence, clinical features and species identification of CL and HIV co-infection in northern Cameroon. A total of 32 466 subjects were clinically screened for CL during a door-to-door survey, followed by parasitological diagnosis in the field laboratory. Amongst the subjects surveyed, 146 (0.4%) were diagnosed with active CL. Seven (4.8%) of these 146 CL patients tested positive for HIV-1 and/or HIV-2. The number of lesions per CL patient ranged from 1 to 20. Three of…

AdultMalemedicine.medical_specialtyAdolescentCross-sectional studyAIDS-Related Opportunistic InfectionsAntiprotozoal AgentsLeishmaniasis CutaneousPolymerase Chain ReactionYoung AdultCutaneous leishmaniasisInternal medicineEpidemiologyHIV SeropositivitymedicineHumansLeishmania majorCameroonYoung adultChildAgedLeishmania majorbiologyAIDS-Related Opportunistic Infectionsbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesInfantGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationVirologyInfectious DiseasesCross-Sectional StudiesChild PreschoolHIV-2CoinfectionHIV-1ParasitologyFemalePublic HealthbusinessTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Variable geographic distribution of Blastocystis subtypes and its potential implications.

2012

Blastocystis is a common intestinal micro-eukaryote found in both humans and non-human hosts and known to be genetically very diverse. It has been divided into numerous subtypes (STs), nine of which have been identified in humans to date. Surveys of ST prevalence have started to emerge over the past few years but to date no data are available for any African country except Egypt and Tanzania. In this study, we determined the prevalence of Blastocystis STs in populations from Libya, Liberia and Nigeria, as well as expanding the dataset available for the UK. A total of 356 Blastocystis STs were identified in this study, 271 from the UK, 38 from Libya, 25 from Liberia and 22 from Nigeria. SSU …

AdultMalemedicine.medical_specialtyAdolescentGenotypeVeterinary (miscellaneous)Blastocystis InfectionsDNA RibosomalYoung AdultEpidemiologyGenetic variationGenotypemedicinePrevalenceRNA Ribosomal 18SHumansChildBlastocystisGenetic diversityMolecular EpidemiologybiologyMolecular epidemiologyGenetic VariationDNA Protozoanbiology.organism_classificationUnited KingdomPhylogeographyPhylogeographyInfectious DiseasesTanzaniaGeographyInsect ScienceAfricaBlastocystisParasitologyFemaleDemographyActa tropica
researchProduct

Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis

2020

Purpose Voriconazole was shown to inhibit ergosterol synthesis in various acanthamoeba species. The purpose of this study was to evaluate the clinical outcome of treatment with supplemental topical voriconazole in patients with acanthamoeba keratitis (AK). Methods All patients who had been treated for AK with voriconazole 1% drops in conjunction with topical first-line antiacanthamoeba therapy composed of polyhexamethylene biguanide (PHMB) 0.02% and propamidine isethionate 0.1% (Brolene) between November 2014 and August 2017 at the Department of Ophthalmology, University Medical Center Mainz, were included. The main outcomes were treatment failure and recurrence rate. Secondary outcomes wer…

AdultMalemedicine.medical_specialtyAntifungal AgentsVisual acuitymedicine.drug_classAntiprotozoal AgentsVisual AcuityAcanthamoebaCorneaYoung Adult03 medical and health sciences0302 clinical medicinePharmacotherapymedicineAnimalsHumansIn patientEye Infections ParasiticAgedRetrospective StudiesAged 80 and overVoriconazoleDose-Response Relationship Drugbusiness.industryBiguanideRetrospective cohort studyMiddle AgedEye infectionmedicine.diseaseDermatologyBenzamidinesOphthalmologyAcanthamoeba KeratitisAcanthamoeba keratitis030221 ophthalmology & optometryDrug Therapy CombinationFemaleVoriconazoleOphthalmic Solutionsmedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up Studiesmedicine.drugCornea
researchProduct